Evaluation of TMS Visual Outcome
ConditionCataract Surgery Experience
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-80
SponsorShanghai High Myopia Study Group
About this trial
The goal of this clinical trial is to learn if transcranial magnetic stimulation (TMS) can improve the visual outcomes in patients after cataract surgery. The main question it aims to answer is:
• Does TMS improve the visual outcome in patients after cataract surgery? Researchers will compare TMS to the sham-controlled treatment (exposure to recorded sounds of pulses without real magnetic stimulation) to see if TMS works to improve the visual outcomes of patients after cataract surgery.
Participants will
* Undergo TMS treatment or a sham-controlled treatment for consecutive 5 days. * Visit the clinic once every 2 weeks for checkups and tests.
Eligibility criteria
Qualifiers
Post cataract surgery
Best-corrected visual acuity less than 0.1logMAR
Disqualifiers
Diagnosed with cognitive impairment or mental disorders and unable to cooperate with treatment;
Diagnosed with significant opacity of refractive media that affects observation of visual function;
History of epileptic seizures;
Long term use of psychotropic drugs；
Trial design
Treatments tested in this trial
- TMS
- control group
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov